Cargando…
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
Mitogen-activated protein kinase (MAPK) signaling networks serve to regulate a wide range of physiologic and cancer-associated cell processes. For instance, a variety of oncogenic mutations often lead to hyperactivation of MAPK signaling, thereby enhancing tumor cell proliferation and disease progre...
Autores principales: | Kumar, Sandeep, Principe, Daniel R., Singh, Sunil Kumar, Viswakarma, Navin, Sondarva, Gautam, Rana, Basabi, Rana, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168889/ https://www.ncbi.nlm.nih.gov/pubmed/31936067 http://dx.doi.org/10.3390/ph13010009 |
Ejemplares similares
-
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3
por: Singh, Sunil Kumar, et al.
Publicado: (2021) -
Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8(+) T cells
por: Kumar, Sandeep, et al.
Publicado: (2020) -
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis
por: Viswakarma, Navin, et al.
Publicado: (2017) -
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma
por: Vishnoi, Kanchan, et al.
Publicado: (2022) -
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2(+) breast cancer by ceramide-loaded nanoparticles
por: Kumar, Sandeep, et al.
Publicado: (2022)